ARYx Therapeutics, Inc.
ARYX
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Net Income | -18.33M | -23.96M | -29.72M | -33.17M | -40.43M |
| Total Depreciation and Amortization | 949.00K | 926.00K | 1.04M | 1.08M | 1.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.24M | 1.65M | 2.13M | 2.21M | 2.57M |
| Change in Net Operating Assets | -3.93M | -1.42M | -3.16M | -5.09M | -2.76M |
| Cash from Operations | -20.07M | -22.81M | -29.71M | -34.97M | -39.53M |
| Capital Expenditure | -52.00K | -52.00K | -64.00K | -141.00K | -127.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.16M | 10.97M | 10.59M | 8.56M | 5.76M |
| Cash from Investing | 8.11M | 10.92M | 10.53M | 8.41M | 5.63M |
| Total Debt Issued | 6.29M | -- | -- | -- | 1.00M |
| Total Debt Repaid | -5.47M | -5.90M | -4.39M | -2.99M | -1.56M |
| Issuance of Common Stock | 7.52M | 7.54M | 7.65M | 1.26M | 20.58M |
| Repurchase of Common Stock | -55.00K | -55.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -219.00K | -219.00K | -219.00K | -311.00K | -92.00K |
| Cash from Financing | 8.07M | 1.37M | 3.04M | -2.04M | 19.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.89M | -10.53M | -16.14M | -28.59M | -13.97M |